Nitro-L-arginine augments the endothelin-1 content of cerebrospinal fluid induced by cerebral ischemia

Brain Res. 1995 Jun 26;684(1):99-102. doi: 10.1016/0006-8993(95)00438-v.

Abstract

The effect of nitro-L-arginine (NLA), inhibitor of NO synthase, on ET-1 content in cerebrospinal fluid (CSF) and on the vascular system was investigated in global ischemia/reperfusion of Mongolian gerbils. The results indicate that NLA induced a prolonged (2-3-fold) increase of ET-1 concentration above that seen in the CSF of untreated animals during ischemia/reperfusion. Both the transient and prolonged rise of ET-1 content observed in the CSF coincided with the reduction in the cerebral blood flow seen in untreated and NLA-treated gerbils, respectively, at the time of reperfusion.

MeSH terms

  • Animals
  • Arginine / analogs & derivatives*
  • Arginine / pharmacology
  • Brain Ischemia / blood
  • Brain Ischemia / cerebrospinal fluid*
  • Cerebrovascular Circulation
  • Endothelins / blood
  • Endothelins / cerebrospinal fluid*
  • Enzyme Inhibitors / pharmacology*
  • Gerbillinae
  • Nitroarginine
  • Osmolar Concentration
  • Reperfusion
  • Time Factors

Substances

  • Endothelins
  • Enzyme Inhibitors
  • Nitroarginine
  • Arginine